These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9617040)

  • 21. Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether.
    Botros SS; Mahmoud MR; Moussa MM; Nosseir MM
    J Infect; 2007 Nov; 55(5):470-7. PubMed ID: 17868901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection.
    Hassan SI; Ali I; Nessim NG; Amer NM; Abd el Kader el Khafif M; Ashour A; el Mohandes M
    Arzneimittelforschung; 2003; 53(6):440-4. PubMed ID: 12872615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni.
    Mahmoud MR; Botros SS
    J Parasitol; 2005 Feb; 91(1):175-8. PubMed ID: 15856895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
    el-Shafei MM; Mattar MA; Afify HA
    J Egypt Soc Parasitol; 2002 Aug; 32(2):551-60. PubMed ID: 12214932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a combination of metrifonate and praziquantel in the treatment of Schistosoma mansoni infection in albino mice.
    Ebeid FA
    Arzneimittelforschung; 1995 Apr; 45(4):519-21. PubMed ID: 7779154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study].
    Chapadeiro E; Pitanga LC
    Rev Soc Bras Med Trop; 1997; 30(1):53-6. PubMed ID: 9026832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antischistosomal effects of praziquantel, its alkaline hydrolysis and sun decomposed products on experimentally S. mansoni infected albino mice. (A) Efficacy assessment based on clinicopathological findings.
    Suleiman MI; Akarim EI; Ibrahim KE; Saad AM; Mohammed AE; Ahmed BM; Sulaiman SM
    J Egypt Soc Parasitol; 2004 Apr; 34(1):131-42. PubMed ID: 15143740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni.
    El-Lakkany N; Nosseir M
    APMIS; 2007 Mar; 115(3):184-94. PubMed ID: 17367463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: an immunohistochemical descriptive study.
    Abdel Fattah NS; Ahmed NS
    Exp Parasitol; 2012 Jan; 130(1):58-62. PubMed ID: 22019417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations of direct fluorescent antibody test and serum bile acids levels following praziquantel treatment in Schistosoma mansoni experimentally infected mice.
    Khalil HM; Bebars MA; Abdallah HM; el-Zayyat EA; Ismail MS
    J Egypt Soc Parasitol; 1995 Dec; 25(3):583-97. PubMed ID: 8586855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice.
    Montasser MF; Younis TA; Fahmy IA; Sabry NM; el-Monayerhy MS; Rashad MS
    J Egypt Soc Parasitol; 1994 Apr; 24(1):155-65. PubMed ID: 8169437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
    Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
    J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological manipulation of the chronic granulomatous reactions in the livers of mice infected with schistosomiasis.
    Rainsford KD
    Int J Tissue React; 1985; 7(1):35-9. PubMed ID: 4008174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Schistosoma mansoni infection and treatment on drug metabolizing enzymes.
    Ebeid FA; Seif el-Din SH; Ezzat AR
    Arzneimittelforschung; 2000 Sep; 50(9):867-74. PubMed ID: 11050708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced efficacy of praziquantel treatment in mice vaccinated with radiation attenuated cercariae of Schistosoma mansoni.
    el-Fakahany AF; Ahmed MM; Abdel-Aziz SM; Abdalla KF; Afifi LM; Khamis NS
    J Egypt Soc Parasitol; 1995 Apr; 25(1):107-13. PubMed ID: 7602152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of praziquantel on the distribution of interstitial collagen types I and III and basement membrane collagen types IV and V in murine hepatic schistosomiasis.
    el-Badrawy NM; Abdel Hadi AM; Voss B; Metwally AA; Ebeid F
    Trans R Soc Trop Med Hyg; 1991; 85(6):752-5. PubMed ID: 1801346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of experimental schistosomiasis mansoni with praziquantel alone and combined with cimetidine.
    Ebeid FA; Metwally AA; Botros SS; Bennet JL
    Arzneimittelforschung; 1994 Nov; 44(11):1268-70. PubMed ID: 7888012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households.
    Botros S; Sayed H; El-Dusoki H; Sabry H; Rabie I; El-Ghannam M; Hassanein M; El-Wahab YA; Engels D
    Am J Trop Med Hyg; 2005 Feb; 72(2):119-23. PubMed ID: 15741544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of anti-schistosomal treatment on schistosomal hepatic pathology: an experimental study in Syrian golden hamsters.
    Moustafa FE; Hamouda MM; el-Shazly AM; Sheha G; Hamid S; el-Naggar HM; Habib FS; Morsy TA
    J Egypt Soc Parasitol; 1996 Aug; 26(2):517-24. PubMed ID: 8754659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.